Trademark: 87519680
Word
DAACS
Status
Dead
Status Code
606
Status Date
Monday, September 3, 2018
Serial Number
87519680
Mark Type
4000
Filing Date
Friday, July 7, 2017
Published for Opposition
Tuesday, December 5, 2017
Abandoned Date
Monday, September 3, 2018

Trademark Owner History
Axcella Health Inc. - Owner At Publication

Classifications
1 Chemical and biochemical compounds, proteins, polypeptides and peptides, amino acids, vitamins, minerals, nutrients and nutritive products, and pharmaceutical excipients for use in scientific and medical research; chemical and biochemical compounds, proteins, polypeptides and peptides, amino acids, vitamins, minerals, and nutrients and nutritive products for use in the manufacture of beverages, food products and food supplements for human and non-human use; chemical and biochemical compounds, proteins, polypeptides and peptides, amino acids, vitamins, minerals, nutrients and nutritive products, and pharmaceutical excipients for use in the manufacture of pharmaceutical preparations, medicines, medical foods, nutraceuticals, and dietary and nutritional foods and supplements; chemical and biochemical compounds, proteins, polypeptides, peptides, amino acids, vitamins, minerals, and nutrients and nutritive products being an ingredient in the manufacture of pharmaceutical preparations for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the central nervous system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, and muscle, bones, joints, and whole body movement; chemical and biochemical compounds, proteins, polypeptides, peptides, amino acids, vitamins, minerals, and nutrients and nutritive products being an ingredient in the manufacture of pharmaceutical preparations for the treatment or prevention of muscle loss, metabolic conditions and diseases, gastrointestinal conditions and diseases, neurological conditions and diseases, cancer, osteoporosis, inflammatory conditions and diseases, genetic conditions and diseases, muscle diseases and disorders, hepatic conditions and diseases, fibrosis, malnutrition, atrophic diseases and conditions, epilepsy, sarcopenia, myopathies, neuropathies, neurodegenerative diseases, traumatic brain injury, concussion, movement disorders, dystrophies, anemias, and orphan diseases; chemical and biochemical compounds, proteins, polypeptides and peptides, amino acids, vitamins, minerals, nutrients and nutritive products, and pharmaceutical excipients for in vitro medical research and in vivo scientific research
5 pharmaceutical preparations and agents for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; proteins, polypeptides, peptides, amino acids, and small molecules being a featured component of pharmaceutical preparations for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; medicines, namely, proteins, biomolecules in the nature of polypeptides and peptides, amino acids, and small molecules in the nature of organic compounds and amino acid metabolites for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; medical foods, namely, food that is intended for the specific dietary management of a disease or condition; nutraceuticals for treating or restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; dietary and nutritional supplements
DEFINED AMINO ACID COMPOSITION

Trademark Events
Sep 4, 2018
Abandonment Notice Mailed - No Use Statement Filed
Sep 3, 2018
Abandonment - No Use Statement Filed
Jan 30, 2018
Noa E-Mailed - Sou Required From Applicant
Dec 5, 2017
Official Gazette Publication Confirmation E-Mailed
Dec 5, 2017
Published For Opposition
Nov 15, 2017
Notification Of Notice Of Publication E-Mailed
Oct 27, 2017
Assigned To Lie
Oct 11, 2017
Approved For Pub - Principal Register
Oct 11, 2017
Examiner's Amendment Entered
Oct 11, 2017
Notification Of Examiners Amendment E-Mailed
Oct 11, 2017
Examiners Amendment E-Mailed
Oct 11, 2017
Examiners Amendment -Written
Oct 6, 2017
Notification Of Non-Final Action E-Mailed
Oct 6, 2017
Non-Final Action E-Mailed
Oct 6, 2017
Non-Final Action Written
Oct 3, 2017
Assigned To Examiner
Sep 20, 2017
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 20, 2017
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 14, 2017
New Application Office Supplied Data Entered In Tram
Jul 11, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24